1-8 of 8
Katherine Vandris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Evaluation of the World Health Organization Criteria for the Diagnosis of Polycythemia Vera,

Richard T. Silver, MD, William Chow, Katherine Vandris, Ivy Tam, Anita Narayan, Maria Teresa De Sancho, MD, Attilio Orazi, MD, Stanley J. Goldsmith
Journal: Blood
Blood (2011) 118 (21): 3837.
https://doi.org/10.1182/blood.V118.21.3837.3837
Published: 2011
Journal Articles

Recombinant interferon-α may retard progression of early primary myelofibrosis: a preliminary report

Brief Report
Richard T. Silver, Katherine Vandris, Joshua J. Goldman
Journal: Blood
Blood (2011) 117 (24): 6669–6672.
https://doi.org/10.1182/blood-2010-11-320069
Published: 2011
Journal Articles

Normal Serum-Erythropoietin (S-epo) Level at Diagnosis of Polycythemia Vera (PV) Correlates with LowJAK2 V617F Mutant Allele Burden and Indicates Mild Phenotype.

Joshua J. Goldman, Katherine Vandris, Clinical, Research, Coordinator, Fernando Adriano, Clinical, Research, Nurse, Michael Bourla, Clinical, Research, Coordinator, Richard T. Silver, MD
Journal: Blood
Blood (2009) 114 (22): 4978.
https://doi.org/10.1182/blood.V114.22.4978.4978
Published: 2009
Journal Articles

Decrease in JAK2 V617F Allele Burden is Not a Prerequisite to Clinical Response in Patients with Polycythemia Vera (PV).

Richard T. Silver, MD, Katherine Vandris, Joshua J. Goldman, Fernando Adriano, Y. Lynn Wang, MD, PhD, Amy V. Jones, Paul J. Christos, PhD, N. C.P. Cross, PhD
Journal: Blood
Blood (2009) 114 (22): 1908.
https://doi.org/10.1182/blood.V114.22.1908.1908
Published: 2009
Journal Articles

Recombinant Interferon Alpha (rIFNα) May Retard Progression of Early Primary Myelofibrosis (PM) by Reducing Splenomegaly and by Changing Marrow Morphology.

Benjamin Levy, Katherine Vandris, Fernando Adriano, Joshua Goldman, Richard T. Silver
Journal: Blood
Blood (2008) 112 (11): 1758.
https://doi.org/10.1182/blood.V112.11.1758.1758
Published: 2008
Journal Articles

JAK2 V617F Mutational Load in Patients with Polycythemia Vera (PV) Measured by Peripheral Blood DNA Is Associated with Disease Severity.

Richard T. Silver, MD, Katherine Vandris, Y. Lynn Wang, M.D., Ph.D., Paul J. Christos, M.P.H., M.S., Fernando Adriano, R.N., B.S.N., O.C.N., Amy V. Jones, Nicholas C.P. Cross, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2530.
https://doi.org/10.1182/blood.V110.11.2530.2530
Published: 2007
Journal Articles

JAK2 Mutations Are Present in All Cases of Polycythemia Vera.

Y. Lynn Wang, M.D., Ph.D., Katherine Vandris, Amy V. Jones, Nicholas C.P. Cross, Ph.D., Paul J. Christos, M.P.H., M.S., Fernando Adriano, R.N., B.S.N., O.C.N., Richard T. Silver, MD
Journal: Blood
Blood (2007) 110 (11): 4669.
https://doi.org/10.1182/blood.V110.11.4669.4669
Published: 2007
Journal Articles

Chronic Myeloid Leukemia (CML): A Model Disease for Utilizing Evidence Based Guidelines in a Decade of Progress.

Richard T. Silver, MD, Michele Baccarani, MD, Katherine Vandris, Francois Guilhot, MD, Bengt Simonsson, MD, Andreas Hochhaus, MD, Rudiger Hehlmann, MD, the European LeukemiaNet6
Journal: Blood
Blood (2006) 108 (11): 3313.
https://doi.org/10.1182/blood.V108.11.3313.3313
Published: 2006